Jennifer G Rubino, DNP, FNP-BC Registered Nurse - Community Health Medicare: Medicare Enrolled Practice Location: 27 Lewis Ave, Great Barrington, MA 01230 Phone: 413-528-1470 |
Nic'cole Ashley Lambert-talhaoui, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 29 Lewis Ave, Great Barrington, MA 01230 Phone: 413-854-9777 |
Katherine Ryan Waiveris, PMHNP Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 60 Cottage St, Great Barrington, MA 01230 Phone: 413-644-6803 |
News Archive
The most exciting breast cancer conference in Europe, it is the only one that involves all the major players in breast cancer. The conference encourages interaction and collaboration between clinicians, scientists and patients in a partnership of equals to talk not just about scientific advances, but also the ethical, social, political, and practical issues associated with caring for patients with breast cancer. EBCC-9 is expected to attract around 5000 delegates from around 90 countries worldwide.
Amgen (NASDAQ: AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints.
In humans, vitamin D is formed in the skin following its exposure to sunlight. In comparison to the body's own formation of vitamin D, dietary consumption generally makes up only a relatively small proportion of the vitamin D supply to the body.
Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that new data from the PROTECT II study will be presented by William O'Neill, M.D., executive dean for clinical affairs at the University of Miami Miller School of Medicine, and principal investigator for the PROTECT II study, during the late-breaking clinical trials session at the Society for Cardiovascular Angiography and Interventions 2011 Scientific Sessions in Baltimore, Maryland.
Although several monoclonal antibodies against the SARS-CoV-2 spike protein have been developed and clinically tested, little is known about antibodies to the nucleocapsid protein. In a paper published recently in the journal Nature Communications, researchers report a human monoclonal antibody that targets the nucleocapsid protein.
› Verified 6 days ago